跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111 条关于
“CD247”
全部
111
临床试验
40
药物
54
机构
0
资讯
17
去年
Spring-Summer Birth and CD247 Gene Variant Linked to Higher Celiac Disease Risk in Large-Scale Study
上个月
Machine Learning Identifies HNRNPA2B1, RPE, and TAF15 as Potential Stress Granule-Related Biomarkers for Childhood Asthma
2年前
CD47-Targeted Immunotherapies Show Promise in Cancer Treatment
去年
CD47 Expression Predicts Response to Magrolimab Plus Docetaxel in Metastatic NSCLC
去年
HanchorBio's HCB101 Advances in Clinical Trials, Leading Novel CD47-Targeting Immunotherapy Pipeline
去年
Pheast's PHST001, Targeting CD24 'Don't Eat Me' Signal, Enters First-in-Human Trials
5个月前
Pheast Therapeutics Advances PHST001 Anti-CD24 Antibody into Phase 1b Combination Trials
去年
Liminatus Pharma Advances Second-Generation CD47 Inhibitor IBA101 Toward 2027 Clinical Trials
去年
HanchorBio Secures $202M Licensing Deal with Henlius for Novel CD47-Targeting Cancer Immunotherapy
上个月
CD27⁻CD39⁻ CAR T Cell Count Predicts Response at Low Doses, Study Finds
第 1 页,共 2 页
上一页
下一页